Combinations For Hcv Treatment

  • Published: Jul 16, 2008
  • Earliest Priority: Oct 27 2003
  • Family: 1
  • Cited Works: 35
  • Cited by: 0
  • Cites: 56
  • Additional Info: Cited Works Published
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The present invention relates a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The combination acts by interfering with the life cycle of the hepatitis C virus and is therefore useful as an antiviral therapy. As such, the combination may be used for treating or preventing Hepatitis C infections in patients. The invention also relates to compositions comprising the combination of inhibitors. The invention also relates to kits and pharmaceutical packs comprising a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The invention also relates to processes for preparing these compositions, combinations, kits, and packs.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 16, 2008
  • Application: Oct 27, 2004
    EP EP 08102792 A
  • Priority: Oct 27, 2004
    EP EP 04810032 A
  • Priority: Oct 27, 2003
    US US 51485303 P

Download Citation


Sign in to the Lens

Feedback